Immunocore Holdings (IMCR) Assets (2019 - 2026)

Immunocore Holdings (IMCR) has reported Assets for 8 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.

• Quarterly Assets rose 4.29% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 4.29% YoY) and the FY2025 annual result came in at $1.1 billion, up 5.72% from the prior year.
• Assets held at $1.1 billion in Q1 2026 per IMCR's latest filing, from $1.1 billion in the prior quarter.
• Over the last five years, Assets for IMCR reached as high as $1.1 billion in Q3 2025 and fell as low as $510.8 million in Q4 2022.
• A 5-year average of $895.9 million and a median of $1.0 billion in 2024 frame the typical range for Assets.
• Annual changes were most pronounced in 2024 — Assets soared 85.71% — and 2025, when it increased 1.65%.
• Year by year, Assets stood at $510.8 million in 2022, then gained by 16.87% to $597.0 million in 2023, then jumped by 69.1% to $1.0 billion in 2024, then increased by 5.72% to $1.1 billion in 2025, then rose by 0.45% to $1.1 billion in 2026.
• According to Business Quant data, Assets over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.